Generation of three human iPSC lines from PLAN (PLA2G6-associated neurodegeneration) patients

Machuca, Candela; Correa Vela, Marta; García-Navas, Deyanira; Darling, Alejandra; Villalón-García, Irene; Sánchez-Alcázar, José Antonio; Perez Dueñas, Belen

dc.contributor	Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author	Machuca, Candela
dc.contributor.author	Correa Vela, Marta
dc.contributor.author	García-Navas, Deyanira
dc.contributor.author	Darling, Alejandra
dc.contributor.author	Villalón-García, Irene
dc.contributor.author	Sánchez-Alcázar, José Antonio
dc.contributor.author	Perez Dueñas, Belen
dc.date.accessioned	2022-01-12T11:32:36Z
dc.date.available	2022-01-12T11:32:36Z
dc.date.issued	2021-05
dc.identifier.citation	Machuca C, Correa-Vela M, García-Navas D, Darling A, Villalón-García I, Sánchez-Alcázar JA, et al. Generation of three human iPSC lines from PLAN (PLA2G6-associated neurodegeneration) patients. Stem Cell Res. 2021 May;53:102338.
dc.identifier.issn	1873-5061
dc.identifier.uri	https://hdl.handle.net/11351/6763
dc.description	Neurodegeneració; Mutació
dc.description.sponsorship	This work was supported by the Instituto de Salud Carlos III (ISCIII) - Subdirección General de Evaluación y Fomento de la Investigación [PI18/00147to CE and PI18/01319 to BPD], and by the Generalitat Valenciana [PROMETEO/2018/135], within the framework of the National R + D + I Plan co-funded with ERDF funds. CM has a CIPF-PhD fellowship [P.I.06/2017]. Part of the equipment employed in this work has been funded by Generalitat Valenciana and co-financed with ERDF funds (OP ERDF of Comunitat Valenciana 2014–2020).
dc.language.iso	eng
dc.publisher	Elsevier
dc.relation.ispartofseries	Stem Cell Research;53
dc.rights	Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.source	Scientia
dc.subject	Sistema nerviós - Degeneració
dc.subject	Malalties rares
dc.subject	Genètica
dc.subject.mesh	Neurodegenerative Diseases
dc.subject.mesh	Induced Pluripotent Stem Cells
dc.title	Generation of three human iPSC lines from PLAN (PLA2G6-associated neurodegeneration) patients
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	10.1016/j.scr.2021.102338
dc.subject.decs	enfermedades neurodegenerativas
dc.subject.decs	células madre pluripotentes inducidas
dc.relation.publishversion	https://doi.org/10.1016/j.scr.2021.102338
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.audience	Professionals
dc.contributor.organismes	Institut Català de la Salut
dc.contributor.authoraffiliation	[Machuca C] Unit of Rare Neurodegenerative Diseases, Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain. Rare Diseases Joint Units, CIPF-IIS La Fe & INCLIVA, Valencia, Spain. Stem Cells Therapies in Neurodegenerative Diseases Lab, Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain. [Correa-Vela M] Servei de Neurologia Pediàtrica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. [García-Navas D] Department of Pediatric Neurology. Hospital Universitario San Pedro de Alcántara, Cáceres, Spain. [Darling A] Unit of Pediatric Movement Disorders, Hospital Sant Joan de Déu, Barcelona, Spain. [Villalón-García I, Sánchez-Alcázar JA] Centro Andaluz de Biología del Desarrollo (CABD-CSIC), Universidad Pablo de Olavide, Seville, Spain. Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Madrid, Spain. [Pérez-Dueñas B] Servei de Neurologia Pediàtrica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain
dc.identifier.pmid	34087982
dc.identifier.wos	000663439300012
dc.relation.projectid	info:eu-repo/grantAgreement/ES/PE2013-2016/PI18%2F01319
dc.rights.accessrights	info:eu-repo/semantics/openAccess